{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:46:15Z","timestamp":1791042375663,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.bcp.2003.11.010","type":"journal-article","created":{"date-parts":[[2004,1,15]],"date-time":"2004-01-15T05:19:27Z","timestamp":1074143967000},"page":"1269-1278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Uridine diphosphate sugar-selective conjugation of an aldose reductase inhibitor (AS-3201) by UDP-glucuronosyltransferase 2B subfamily in human liver microsomes"],"prefix":"10.1016","volume":"67","author":[{"given":"Kenji","family":"Toide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Terauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Kamataki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2003.11.010_BIB1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008571-199708000-00001","article-title":"The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence","volume":"7","author":"Mackenzie","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bcp.2003.11.010_BIB2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0079-6603(08)60882-X","article-title":"Gene structure at the human UGT1 locus creates diversity in isozyme structure, substrate specificity, and regulation","volume":"51","author":"Owens","year":"1995","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"10.1016\/j.bcp.2003.11.010_BIB3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1006\/geno.1994.1531","article-title":"Isolation of a human YAC contig encompassing a cluster of UGT2 genes and its regional localization to chromosome 4q13","volume":"23","author":"Monaghan","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.bcp.2003.11.010_BIB4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1006\/jmbi.1999.3374","article-title":"Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4","volume":"295","author":"Turgeon","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bcp.2003.11.010_BIB5","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1016\/S0021-9258(17)32403-1","article-title":"Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man","volume":"269","author":"Bosma","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2003.11.010_BIB6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","article-title":"Human UDP-glucuronosyltransferases: metabolism, expression, and disease","volume":"40","author":"Tukey","year":"2000","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2003.11.010_BIB7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-5347(24)06178-0","article-title":"Metabolic fate of phenobarbital in man. N-Glucoside formation","volume":"7","author":"Tang","year":"1979","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2003.11.010_BIB8","first-page":"45","article-title":"Amobarbital metabolism in man: N-glucoside formation","volume":"21","author":"Tang","year":"1978","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.bcp.2003.11.010_BIB9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF03189937","article-title":"N1-glucosides as urinary metabolites of sulphadimidine, sulphamerazine and sulphamethoxazole","volume":"13","author":"Ahmad","year":"1988","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.bcp.2003.11.010_BIB10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0163-7258(90)90034-Y","article-title":"Drug glucosidation","volume":"46","author":"Tang","year":"1990","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2003.11.010_BIB11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0378-4347(96)00437-9","article-title":"High-performance liquid chromatographic analysis of phenobarbital and phenobarbital metabolites in human urine","volume":"691","author":"Paibir","year":"1997","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.bcp.2003.11.010_BIB12","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1021\/jm9802968","article-title":"Novel, highly potent aldose reductase inhibitors: (R)-(\u2212)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-3\u2032-pyrrolidine-1,2\u2032,3,5\u2032-tetrone (AS-3201) and its congeners","volume":"41","author":"Negoro","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2003.11.010_BIB13","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1021\/bi0102813","article-title":"Stereospecific interaction of a novel spirosuccinimide type aldose reductase inhibitor, AS-3201, with aldose reductase","volume":"40","author":"Kurono","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2003.11.010_BIB14","unstructured":"Toide K, Matsushita H, Hashizume T, Terauchi Y, Fujii T. In vitro metabolism of aldose reductase inhibitor AS-3201 in human liver microsomes. Ninth North American ISSX Meeting, 1999 Oct 24\u201328; Nashville, TN, Abstract No. 155."},{"key":"10.1016\/j.bcp.2003.11.010_BIB15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0378-4347(87)80468-1","article-title":"High-performance liquid chromatographic determination of the diastereomers of 1-(\u03b1-d-glucopyranosyl)amobarbital in urine","volume":"422","author":"Soine","year":"1987","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.bcp.2003.11.010_BIB16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0168-8278(00)80268-8","article-title":"Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene","volume":"33","author":"Raijmakers","year":"2000","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2003.11.010_BIB17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0731-7085(00)00491-X","article-title":"Determination of UDP-glucuronosyltransferase UGT1A6 activity in human and rat liver microsomes by HPLC with UV detection","volume":"25","author":"Hanioka","year":"2001","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bcp.2003.11.010_BIB18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2125.1991.tb05607.x","article-title":"The effect of various drugs on the glucuronidation of zidovudine (azidothymidine AZT) by human liver microsomes","volume":"32","author":"Sim","year":"1991","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2003.11.010_BIB19","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0006-2952(02)00994-2","article-title":"Reverse geometrical selectivity in glucuronidation and sulfation of cis- and trans-4-hydroxytamoxifens by human liver UDP-glucuronosyltransferases and sulfotransferases","volume":"63","author":"Nishiyama","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2003.11.010_BIB20","doi-asserted-by":"crossref","first-page":"15127","DOI":"10.1016\/S0021-9258(18)82446-2","article-title":"A novel UDP-Glc-specific glucosyltransferase catalyzing the biosynthesis of 6-O-glucosides of bile acids in human liver microsomes","volume":"268","author":"Radominska","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2003.11.010_BIB21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0065-2490(05)80006-1","article-title":"Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological research","volume":"26","author":"Crespi","year":"1995","journal-title":"Adv. Drug Res."},{"key":"10.1016\/j.bcp.2003.11.010_BIB22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1081\/DMR-100101944","article-title":"Structural and functional studies of UDP-glucuronosyltransferases","volume":"31","author":"Radominska-Pandya","year":"1999","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bcp.2003.11.010_BIB23","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0090-9556(24)14947-1","article-title":"Azelastine N-demethylation by cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in human liver microsomes: evaluation of approach to predict the contribution of multiple CYPs","volume":"27","author":"Nakajima","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2003.11.010_BIB24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/mol.52.2.212","article-title":"Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue","volume":"52","author":"Strassburg","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2003.11.010_BIB25","doi-asserted-by":"crossref","first-page":"8719","DOI":"10.1074\/jbc.273.15.8719","article-title":"Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8","volume":"273","author":"Strassburg","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2003.11.010_BIB26","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0090-9556(25)07570-1","article-title":"Stable expression of a human liver UDPglucuronosyltransferase (UGT2B15) with activity towards steroid and xenobiotic substrates","volume":"22","author":"Green","year":"1994","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2003.11.010_BIB27","doi-asserted-by":"crossref","first-page":"22855","DOI":"10.1074\/jbc.271.37.22855","article-title":"Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids","volume":"271","author":"Beaulieu","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2003.11.010_BIB28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00008571-199708000-00007","article-title":"Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene","volume":"7","author":"L\u00e9vesque","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bcp.2003.11.010_BIB29","first-page":"256","article-title":"Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism","volume":"25","author":"Fitzsimmons","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2003.11.010_BIB30","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0022-3565(24)38970-0","article-title":"Scaling drug biotransformation data from cDNA-expressed cytochrome P-450 to human liver: a comparison of relative activity factors and human liver abundance in studies of mirtazapine metabolism","volume":"295","author":"Stormer","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2003.11.010_BIB31","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0090-9556(24)13680-X","article-title":"Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches","volume":"28","author":"Venkatakrishnan","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2003.11.010_BIB32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj3030233","article-title":"Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation","volume":"303","author":"Senafi","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2003.11.010_BIB33","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0090-9556(25)07355-6","article-title":"Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein","volume":"24","author":"Green","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2003.11.010_BIB34","first-page":"507","article-title":"Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3","volume":"26","author":"Green","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2003.11.010_BIB35","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.1016\/S0021-9258(18)32428-1","article-title":"Evidence for an active site arginine in UDP-glucuronyltransferase","volume":"258","author":"Zakim","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2003.11.010_BIB36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1124\/dmd.31.1.37","article-title":"Acyl glucuronidation and glucosidation of a new and selective endothelin ET(A) receptor antagonist in human liver microsomes","volume":"31","author":"Tang","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2003.11.010_BIB37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0006-2952(02)01522-8","article-title":"Glucosidation of hyodeoxycholic acid by UDP-glucuronosyltransferase 2B7","volume":"65","author":"Mackenzie","year":"2003","journal-title":"Biochem. Pharmacol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629520300902X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629520300902X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:58:58Z","timestamp":1762095538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629520300902X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S000629520300902X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2003.11.010","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uridine diphosphate sugar-selective conjugation of an aldose reductase inhibitor (AS-3201) by UDP-glucuronosyltransferase 2B subfamily in human liver microsomes","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2003.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}